© 2021 KOSU
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

Oklahoma Will Return Hydroxychloroquine Stockpile For $2M Refund

Hydroxychloroquine, a drug used to prevent malaria and treat certain autoimmune conditions, is being studied to treat or prevent COVID-19.
George Frey
/
AFP via Getty Images
Hydroxychloroquine, a drug used to prevent malaria and treat certain autoimmune conditions, is being studied to treat or prevent COVID-19.

Oklahoma officials announced on Friday they are returning the state’s stockpile of hydroxychloroquine.

At the beginning of the pandemic, the U.S. Food and Drug Administration approved hydroxychloroquine to treat COVID-19. The medication became a household name once then-President Donald Trump hailed it as a potential game changer.

Despite controversy at the time, Oklahoma health officials bought more than $2 million dollars worth of doses and built a stockpile. The FDA soon revoked the approval, as regulators found the drug to be not only ineffective but, in some cases, dangerous.

Attorney General Mike Hunter announced Friday that his office had reached an agreement with the drug’s manufacturer FFF Enterprises for a full refund.

---

Support this vital local reporting with a donation to KOSU. Click here to give.

Catherine Sweeney reports for StateImpact Oklahoma, focusing on health.
Hey! Did you enjoy this story? We can’t do it without you. We are member-supported, so your donation is critical to KOSU's news reporting and music programming. Help support the reporters, DJs and staff of the station you love.

Here's how:

Related Content